Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial

Omuro, Antonio; Brandes, Alba A.; Carpentier, Antoine F.; Idbaih, Ahmed; Reardon, David A.; Cloughesy, Timothy; Sumrall, Ashley; Baehring, Joachim; van den Bent, Martin; Bahr, Oliver; Lombardi, Giuseppe; Mulholland, Paul; Tabatabai, Ghazaleh; Lassen, Ulrik; Sepulveda, Juan Manuel; Khasraw, Mustafa; Vauleon, Elodie; Muragaki, Yoshihiro; Di Giacomo, Anna Maria; Butowski, Nicholas; Roth, Patrick; Qian, Xiaozhong; Fu, Alex Z.; Liu, Yanfang; Potter, Von; Chalamandaris, Alexandros-Georgios; Tatsuoka, Kay; Lim, Michael; Weller, Michael

Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial

Autor(en):

Omuro, Antonio; Brandes, Alba A.; Carpentier, Antoine F.; Idbaih, Ahmed; Reardon, David A.; Cloughesy, Timothy; Sumrall, Ashley; Baehring, Joachim; van den Bent, Martin; Bahr, Oliver; Lombardi, Giuseppe; Mulholland, Paul; Tabatabai, Ghazaleh; Lassen, Ulrik; Sepulveda, Juan Manuel; Khasraw, Mustafa; Vauleon, Elodie; Muragaki, Yoshihiro; Di Giacomo, Anna Maria; Butowski, Nicholas; Roth, Patrick; Qian, Xiaozhong; Fu, Alex Z.; Liu, Yanfang; Potter, Von; Chalamandaris, Alexandros-Georgios; Tatsuoka, Kay; Lim, Michael; Weller, Michael

Tübinger Autor(en):

Tabatabai, Ghazaleh

Erschienen in:

Neuro - Oncology (2023), Bd. 25, H. 1, S. 123-134

Verlagsangabe:

Oxford Univ Press Inc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1093/neuonc/noac099

ISSN:

1522-8517